Chicago Partners Investment Group LLC Recursion Pharmaceuticals, Inc. Transaction History
Chicago Partners Investment Group LLC
- $2.81 Billion
- Q4 2024
A detailed history of Chicago Partners Investment Group LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 10,272 shares of RXRX stock, worth $67,589. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,272
Previous 15,974
35.7%
Holding current value
$67,589
Previous $105,000
34.29%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
342Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$224 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$213 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$164 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$114 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$96.5 Million0.44% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.19B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...